Skip to main content

Featured Studies

This web page makes it easy to search for featured research studies at the NIH Clinical Center. You can search for specific studies by entering keywords related to your symptoms in the search box or by using the sort and filter options.


To view a full list of all studies conducted at the NIH Clinical Center, visit Search the Studies.

Filter By

Visit Type

Patient or Healthy Volunteer

Age Group

Institution

Web Page Language

Reset All Filters
4 results
Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer

Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer (En español)

Doctors at the National Institute on Deafness and Other Communication Disorders (NIDCD) are investigating the effectiveness of atorvastatin (a drug used to lower “bad“ cholesterol and fats such as LDL, and triglycerides, and raise “good“ cholesterol such as HDL, in the blood) at reducing the incidence of hearing loss in patients treated with cisplatin for head and neck cancer. (En español)

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 21-DC-0002.
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens into the Human Lung

Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens into the Human Lung (En español)

Researchers at the National Heart, Lung, and Blood Institute in Bethesda, Maryland, are conducting a study to evaluate the airway immunity in adults with a positive TB skin or blood test. With this study, researchers hope to discover better prevention and treatments for TB. (En español)

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 21-H-0027.
COVID-19, Adaptación crónica y respuesta al ejercicio (COVID-CARE): un ensayo controlado aleatorio

COVID-19, Adaptación crónica y respuesta al ejercicio (COVID-CARE): un ensayo controlado aleatorio

Investigadores del Centro Clínico de los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) buscan voluntarios para un estudio que investiga si un programa de ejercicios aeróbicos puede beneficiar a los sobrevivientes de COVID-19.

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 000102-CC.
Hígado graso no alcohólico, respuesta hepática a la glucosa oral y efecto de la semaglutida (NAFLD HEROES)

Hígado graso no alcohólico, respuesta hepática a la glucosa oral y efecto de la semaglutida (NAFLD HEROES)

¿Está buscando un tratamiento para su condición de hígado graso no alcohólico (NAFLD, por sus siglas en inglés) o para la esteatohepatitis no alcohólica (NASH, por sus siglas en inglés)? Investigadores de los Institutos Nacionales de la Salud, buscan voluntarios para participar en este estudio. Por 30 semanas, los participantes recibirán semaglutide (medicina usada para la diabetes tipo 2), esto podría mejorar su hígado y ayudarle a perder peso. El estudio espera entender mejor el daño del hígado y los mejores tratamientos para las personas con estas condiciones.
Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 19-DK-0072.